GLAXOSMITHKLINE FDA Approval ANDA 062690

ANDA 062690

GLAXOSMITHKLINE

FDA Drug Application

Application #062690

Application Sponsors

ANDA 062690GLAXOSMITHKLINE

Marketing Status

Discontinued001

Application Products

001INJECTABLE;INJECTIONEQ 3GM BASE/VIAL0TICARTICARCILLIN DISODIUM

FDA Submissions

ORIG1AP1986-12-19
MANUF (CMC); Manufacturing (CMC)SUPPL2AP1990-02-26
LABELING; LabelingSUPPL3AP1993-02-26
MANUF (CMC); Manufacturing (CMC)SUPPL5AP1996-07-03
MANUF (CMC); Manufacturing (CMC)SUPPL6AP1996-07-03

Submissions Property Types

ORIG1Null0
SUPPL2Null0
SUPPL3Null0
SUPPL5Null0
SUPPL6Null0

CDER Filings

Accessdata Error
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 62690
            [companyName] => Accessdata Error
            [docInserts] => ["",""]
            [products] => []
            [labels] => 
            [originalApprovals] => []
            [supplements] => 
            [actionDate] => 0000-00-00
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.